Starting in January 2026, Dr. Asheley Chapman joined Vanderbilt University as an Assistant Professor in the Department of Chemical and Biomolecular Engineering. Asheley’s research strengthens Vanderbilt’s efforts at the interface of nanotechnology, immunology, and translational medicine.
Dr. Chapman earned her B.A. in Religious Studies from Agnes Scott College before completing her Ph.D. in Biochemistry at the Georgia Institute of Technology. Following her doctoral studies, Dr. Chapman completed postdoctoral training in the immunoengineering laboratory of Professor Darrell Irvine at MIT and the Scripps Research Institute. There, she developed expertise in immune engineering, nanomedicine, and vaccine design, contributing to innovative strategies for modulating immune responses.
At Vanderbilt, the Chapman Lab integrates bioconjugation chemistry, protein engineering, and drug delivery to develop targeted vaccines and therapeutics for infectious diseases and autoimmune disorders. Her group focuses in particular on modulating B cell responses and understanding germinal center biology, with the goal of designing next-generation nanomedicines. We are excited to welcome Dr. Chapman to Vanderbilt and VINSE, and we look forward to the impactful discoveries her group will bring to the VINSE community.